Results 201 to 210 of about 7,911 (231)

A Ferritin-Based Eg95 Nanoparticle Vaccine Adjuvanted with pCpG Eliciting Robust Immune Responses Against Cystic Echinococcosis in Mice Model. [PDF]

Int J Nanomedicine
Gao X, Zhu X, Liu X, Zhou C, Shang Y, Wu T, Jia H, Zhang Z, Li Y, Xin T.   +9 more
europepmc   +1 more source

Follow up study of symptomatic human cystic echinococcosis treatment with albendazole and praziquantel, in Uruguay. [PDF]

BMC Infect Dis
Rosa DD, Figueredo E, Rosas M, Goñi F.
europepmc   +1 more source

The Diagnostic Challenge of Cystic Echinococcosis in Humans: First Assessment of Underreporting Rates in Mongolia. [PDF]

Trop Med Infect Dis
Bold B, Schindler C, Narankhuu U, Shagj A, Bavuujav E, Sodov S, Nyamdorj T, Zinsstag J.   +7 more
europepmc   +1 more source

[Controlling cystic echinococcosis: outlook in the 21st centuryControle da equinococose/hidatidose cística: perspectivas no século XXI]. [PDF]

Rev Panam Salud Publica
Larrieu E, Vieira Alves R, Vigilato M.
europepmc   +1 more source

Prevalence and histopathological analysis of cystic echinococcosis in ruminants of District Narowal, Pakistan: focus on pulmonary involvement. [PDF]

Rev Bras Parasitol Vet
Usman M, Rizwan HM, Sajid MS, Kausar R, Tahir UB, Abbas H, Ateeq MK, Raza M, Maqbool M, Fouad D, Ataya FS.   +10 more
europepmc   +1 more source

A deep learning radiomics model based on CT images for predicting the biological activity of hepatic cystic echinococcosis. [PDF]

Front Physiol
Nijiati M, Tuerdi M, Damola M, Yimit Y, Yang J, Abulaiti A, Mutailifu A, Aihait D, Wang Y, Zou X.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cystic echinococcosis of the bone

Current Opinion in Infectious Diseases, 2023
Purpose of review Cystic echinococcosis (CE) has a wide world distribution causing important morbidity. Osseous involvement is present in less than 4% of the CE cases. Its diagnosis and therapeutic management is full of challenges and low grade of evidence. Recent findings The study
Begoña, Monge-Maillo, Rogelio, Lopez-Velez   +1 more
openaire   +2 more sources

Cystic echinococcosis in the Americas

Parasitology International, 2006
Echinococcus granulosus and related genotypic variants, the agents of cystic hydatid disease, occur widely in the American continents from Alaska and Northern Canada in North America to Tierra del Fuego in South America. Here we review the historical and current distribution and prevalence of these infections throughout the American countries and the ...
Pedro L. Moro, Peter M. Schantz
openaire   +2 more sources

Cystic and alveolar echinococcosis

2013
Echinococcosis of the CNS is very rare. Cystic (CE) and alveolar echininococcosis (AE) vary in their clinical manifestations, course of disease, and prognosis, to the extent that clinicians should look at these two parasitic infections as distinctly different entities. CE causes displacement and pressure atrophy, while AE expands by infiltrative growth.
Marija Stojkovic, Thomas Junghanss
openaire   +3 more sources

An update on immunodiagnosis of cystic echinococcosis

Acta Tropica, 2003
Immunological parameters are increasingly investigated as possible markers for the development of cystic echinococcosis. Among the newer immunologic tests for assessing the host-parasite relationship, assay of immunoglobulin isotypes with the use of distinct parasite antigens and detection of Th1/Th2 cytokine expression are an interesting new approach.
ORTONA E, RIGANO' R, BUTTARI B, DELUNARDO F, IOPPOLO S, MARGUTTI P, PROFUMO E, TEGGI, Antonella, VACCARI S, SIRACUSANO A.   +9 more
openaire   +5 more sources